Your browser doesn't support javascript.
loading
GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate.
Xie, Jianjiang; Ye, Jianheng; Cai, Zhiduan; Luo, Yong; Zhu, Xuejin; Deng, Yulin; Feng, Yuanfa; Liang, Yingke; Liu, Ren; Han, Zhaodong; Liang, Yuxiang; Zheng, Yu; Mo, Rujun; Zhuo, Yangjia; Wu, Yongding; Jiang, Funeng; Zhu, Jianguo; Wu, Chin-Lee; Zhong, Weide.
Afiliação
  • Xie J; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Ye J; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Cai Z; Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Luo Y; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhu X; Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Deng Y; Department of Urology, the Second People's Hospital of Foshan, Affiliated Foshan Hospital of Southern Medical University, Foshan, China.
  • Feng Y; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Liang Y; Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Liu R; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Han Z; Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liang Y; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zheng Y; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Mo R; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhuo Y; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Wu Y; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Jiang F; Department of Urology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Zhu J; Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Wu CL; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhong W; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Cancer Res ; 80(11): 2150-2162, 2020 06 01.
Article em En | MEDLINE | ID: mdl-32179514

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicerolfosfato Desidrogenase / Glicerofosfatos / Metformina / Neoplasias Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicerolfosfato Desidrogenase / Glicerofosfatos / Metformina / Neoplasias Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China